Tammy Romo Sells 2,500 Shares of Tenet Healthcare (NYSE:THC) Stock

Tenet Healthcare Corporation (NYSE:THC) Director Tammy Romo sold 2,500 shares of the stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $260.83, for a total transaction of $652,075.00. Following the completion of the transaction, the director directly owned 28,284 shares in the company, valued at $7,377,315.72. The trade was a 8.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Tammy Romo also recently made the following trade(s):

• On Thursday, August 6th, Tammy Romo sold 4,922 shares of Tenet Healthcare stock. The shares were sold at an average price of $264.15, for a total transaction of $1,300,146.30.

Tenet Healthcare Trading Down 0.1%

Shares of THC stock opened at $259.74 on Wednesday. Tenet Healthcare Corporation has a 12-month low of $157.58 and a 12-month high of $265.32. The company has a market capitalization of $20.91 billion, a PE ratio of 10.02, a price-to-earnings-growth ratio of 0.99 and a beta of 1.23. The firm has a 50 day moving average price of $203.92 and a two-hundred day moving average price of $202.38. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. The company had revenue of $6.04 billion for the quarter, compared to analyst estimates of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter last year, the company earned $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, analysts predict that Tenet Healthcare Corporation will post 21.09 earnings per share for the current year.

Institutional Investors Weigh In On Tenet Healthcare

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Norges Bank bought a new position in shares of Tenet Healthcare in the fourth quarter worth about $248,494,000. Wellington Management Group LLP increased its position in Tenet Healthcare by 1,114.2% during the 4th quarter. Wellington Management Group LLP now owns 1,135,801 shares of the company’s stock worth $225,706,000 after purchasing an additional 1,042,260 shares in the last quarter. Boston Partners lifted its stake in Tenet Healthcare by 38.8% in the 3rd quarter. Boston Partners now owns 3,147,555 shares of the company’s stock valued at $638,958,000 after purchasing an additional 880,413 shares during the last quarter. AQR Capital Management LLC boosted its position in Tenet Healthcare by 62.3% in the third quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock valued at $380,989,000 after buying an additional 720,160 shares in the last quarter. Finally, Alliancebernstein L.P. grew its stake in shares of Tenet Healthcare by 375.7% during the second quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock worth $139,085,000 after buying an additional 624,125 shares during the last quarter. 95.44% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on THC. Piper Sandler set a $308.00 target price on shares of Tenet Healthcare in a research report on Monday, July 27th. Wells Fargo & Company boosted their price objective on shares of Tenet Healthcare from $231.00 to $281.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. TD Cowen raised their target price on shares of Tenet Healthcare from $233.00 to $263.00 and gave the stock a “buy” rating in a report on Monday, July 27th. Raymond James Financial set a $270.00 price target on Tenet Healthcare in a research note on Monday, July 27th. Finally, Wall Street Zen upgraded Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Monday, August 3rd. Seventeen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $272.25.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.